Researchers at the University of Pittsburgh gave transplant recipients certain immune cells from their organ donors. It ...

Several liver transplant recipients have stayed off anti-rejection drugs for at least three years following an experimental ...

One of the first transplant patients to have a skin patch from their donor grafted onto them in a bid to spot organ rejection ...

Add Yahoo as a preferred source to see more of our stories on Google. Eledon's kidney transplant rejection drug Eledon Pharmaceuticals’ lead asset, tegoprubart, is going to late-stage trials in kidney ...

A few transplant patients in a small study were able to stop using immunosuppressive drugs, thanks to pre-transplant cell ...

As Barbara Bowser was preparing for a liver transplant in 2018, doctors at the University of Pittsburgh asked her if she’d be willing to participate in a study.

A novel approach to organ transplantation allowed patients to wean off anti-rejection drugs after two years, according to the results of a phase 3 clinical trial presented Monday. The drugs, called ...

A study of recurrent rejection after pediatric heart transplantation has provided mixed results, showing that while it is occurring less frequently, it continues to be a risk factor for graft loss.

Please provide your email address to receive an email when new articles are posted on . Pain and energy-related outcomes were most common for patients with or without antibody-mediated rejection ...

If an organ in your body (such as the heart, kidneys, or liver) is not working well enough because of an illness or injury, you may need an organ transplant. An organ transplant involves surgically ...

Transplantation of organs or tissues between genetically nonidentical individuals of the same species (and different species) is plagued by rejection and its associated problems. "Foreignness" is ...